INTERFURANYLENE-PROSTACYCLIN DERIVATIVES

    The invention relates to novel interfuranylene-prosta-cyclin derivatives of the general formula (I) wherein R stands for hydrogen or a straight or branched chain C16 alkyl group, an inorganic cation or for the protonated form of a base containing an amino group; R stands for hydrogen, a C1-4 alk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PAL HADHAZY, GYORGY DORMAN, SANDOR VIRAG, PETER KORMOCZI, ISTVAN TOMOSKOZY, JOZSEF IVANICS, KAROLY KANAY, ISTVAN STADLER, MIKLOS KISS, GEZA GALAMBOS, GABOR KOVACS
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PAL HADHAZY
GYORGY DORMAN
SANDOR VIRAG
PETER KORMOCZI
ISTVAN TOMOSKOZY
JOZSEF IVANICS
KAROLY KANAY
ISTVAN STADLER
MIKLOS KISS
GEZA GALAMBOS
GABOR KOVACS
description     The invention relates to novel interfuranylene-prosta-cyclin derivatives of the general formula (I) wherein R stands for hydrogen or a straight or branched chain C16 alkyl group, an inorganic cation or for the protonated form of a base containing an amino group; R stands for hydrogen, a C1-4 alkanoyl or benzoyl group, a monosubstituted benzoyl, trialkylsilyl or an alkoxy-alkyl group; R stands for a straight or branched chain C1-6 alkyl group, a phenyl group optionally substituted by halogen or by a C1-4 alkyl group, a heteroaryl group optionally substituted by halogen or by a C1-4 alkyl group or a cycloalkyl group; A stands for an ethylene or for a cis- or trans-vinylene or -C IDENTICAL C- group; B means a chemical bond, a -CHR -, -CHR -CH2- or a -CH2-O- group: and R means hydrogen or a C1-4 alkyl group. The compounds of the formula (I) can be used therapeutically as platelet aggregation inhibiting, anti-thrombotic, hypotensive and anti-antherosclerotic agents; they are much more stable than the natural prostacyclin derivatives.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU5251486A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU5251486A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU5251486A3</originalsourceid><addsrcrecordid>eNrjZNDw9AtxDXILDXL0i_Rx9XPVDQjyDw5xdI509vH0U3BxDfIMcwzxDHMN5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8Y6hpkamhiYWZo7GhFUAAMUWI_w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INTERFURANYLENE-PROSTACYCLIN DERIVATIVES</title><source>esp@cenet</source><creator>PAL HADHAZY ; GYORGY DORMAN ; SANDOR VIRAG ; PETER KORMOCZI ; ISTVAN TOMOSKOZY ; JOZSEF IVANICS ; KAROLY KANAY ; ISTVAN STADLER ; MIKLOS KISS ; GEZA GALAMBOS ; GABOR KOVACS</creator><creatorcontrib>PAL HADHAZY ; GYORGY DORMAN ; SANDOR VIRAG ; PETER KORMOCZI ; ISTVAN TOMOSKOZY ; JOZSEF IVANICS ; KAROLY KANAY ; ISTVAN STADLER ; MIKLOS KISS ; GEZA GALAMBOS ; GABOR KOVACS</creatorcontrib><description>    The invention relates to novel interfuranylene-prosta-cyclin derivatives of the general formula (I) wherein R stands for hydrogen or a straight or branched chain C16 alkyl group, an inorganic cation or for the protonated form of a base containing an amino group; R stands for hydrogen, a C1-4 alkanoyl or benzoyl group, a monosubstituted benzoyl, trialkylsilyl or an alkoxy-alkyl group; R stands for a straight or branched chain C1-6 alkyl group, a phenyl group optionally substituted by halogen or by a C1-4 alkyl group, a heteroaryl group optionally substituted by halogen or by a C1-4 alkyl group or a cycloalkyl group; A stands for an ethylene or for a cis- or trans-vinylene or -C IDENTICAL C- group; B means a chemical bond, a -CHR -, -CHR -CH2- or a -CH2-O- group: and R means hydrogen or a C1-4 alkyl group. The compounds of the formula (I) can be used therapeutically as platelet aggregation inhibiting, anti-thrombotic, hypotensive and anti-antherosclerotic agents; they are much more stable than the natural prostacyclin derivatives.</description><edition>4</edition><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1986</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19860724&amp;DB=EPODOC&amp;CC=AU&amp;NR=5251486A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19860724&amp;DB=EPODOC&amp;CC=AU&amp;NR=5251486A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAL HADHAZY</creatorcontrib><creatorcontrib>GYORGY DORMAN</creatorcontrib><creatorcontrib>SANDOR VIRAG</creatorcontrib><creatorcontrib>PETER KORMOCZI</creatorcontrib><creatorcontrib>ISTVAN TOMOSKOZY</creatorcontrib><creatorcontrib>JOZSEF IVANICS</creatorcontrib><creatorcontrib>KAROLY KANAY</creatorcontrib><creatorcontrib>ISTVAN STADLER</creatorcontrib><creatorcontrib>MIKLOS KISS</creatorcontrib><creatorcontrib>GEZA GALAMBOS</creatorcontrib><creatorcontrib>GABOR KOVACS</creatorcontrib><title>INTERFURANYLENE-PROSTACYCLIN DERIVATIVES</title><description>    The invention relates to novel interfuranylene-prosta-cyclin derivatives of the general formula (I) wherein R stands for hydrogen or a straight or branched chain C16 alkyl group, an inorganic cation or for the protonated form of a base containing an amino group; R stands for hydrogen, a C1-4 alkanoyl or benzoyl group, a monosubstituted benzoyl, trialkylsilyl or an alkoxy-alkyl group; R stands for a straight or branched chain C1-6 alkyl group, a phenyl group optionally substituted by halogen or by a C1-4 alkyl group, a heteroaryl group optionally substituted by halogen or by a C1-4 alkyl group or a cycloalkyl group; A stands for an ethylene or for a cis- or trans-vinylene or -C IDENTICAL C- group; B means a chemical bond, a -CHR -, -CHR -CH2- or a -CH2-O- group: and R means hydrogen or a C1-4 alkyl group. The compounds of the formula (I) can be used therapeutically as platelet aggregation inhibiting, anti-thrombotic, hypotensive and anti-antherosclerotic agents; they are much more stable than the natural prostacyclin derivatives.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1986</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDw9AtxDXILDXL0i_Rx9XPVDQjyDw5xdI509vH0U3BxDfIMcwzxDHMN5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8Y6hpkamhiYWZo7GhFUAAMUWI_w</recordid><startdate>19860724</startdate><enddate>19860724</enddate><creator>PAL HADHAZY</creator><creator>GYORGY DORMAN</creator><creator>SANDOR VIRAG</creator><creator>PETER KORMOCZI</creator><creator>ISTVAN TOMOSKOZY</creator><creator>JOZSEF IVANICS</creator><creator>KAROLY KANAY</creator><creator>ISTVAN STADLER</creator><creator>MIKLOS KISS</creator><creator>GEZA GALAMBOS</creator><creator>GABOR KOVACS</creator><scope>EVB</scope></search><sort><creationdate>19860724</creationdate><title>INTERFURANYLENE-PROSTACYCLIN DERIVATIVES</title><author>PAL HADHAZY ; GYORGY DORMAN ; SANDOR VIRAG ; PETER KORMOCZI ; ISTVAN TOMOSKOZY ; JOZSEF IVANICS ; KAROLY KANAY ; ISTVAN STADLER ; MIKLOS KISS ; GEZA GALAMBOS ; GABOR KOVACS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU5251486A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1986</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PAL HADHAZY</creatorcontrib><creatorcontrib>GYORGY DORMAN</creatorcontrib><creatorcontrib>SANDOR VIRAG</creatorcontrib><creatorcontrib>PETER KORMOCZI</creatorcontrib><creatorcontrib>ISTVAN TOMOSKOZY</creatorcontrib><creatorcontrib>JOZSEF IVANICS</creatorcontrib><creatorcontrib>KAROLY KANAY</creatorcontrib><creatorcontrib>ISTVAN STADLER</creatorcontrib><creatorcontrib>MIKLOS KISS</creatorcontrib><creatorcontrib>GEZA GALAMBOS</creatorcontrib><creatorcontrib>GABOR KOVACS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAL HADHAZY</au><au>GYORGY DORMAN</au><au>SANDOR VIRAG</au><au>PETER KORMOCZI</au><au>ISTVAN TOMOSKOZY</au><au>JOZSEF IVANICS</au><au>KAROLY KANAY</au><au>ISTVAN STADLER</au><au>MIKLOS KISS</au><au>GEZA GALAMBOS</au><au>GABOR KOVACS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INTERFURANYLENE-PROSTACYCLIN DERIVATIVES</title><date>1986-07-24</date><risdate>1986</risdate><abstract>    The invention relates to novel interfuranylene-prosta-cyclin derivatives of the general formula (I) wherein R stands for hydrogen or a straight or branched chain C16 alkyl group, an inorganic cation or for the protonated form of a base containing an amino group; R stands for hydrogen, a C1-4 alkanoyl or benzoyl group, a monosubstituted benzoyl, trialkylsilyl or an alkoxy-alkyl group; R stands for a straight or branched chain C1-6 alkyl group, a phenyl group optionally substituted by halogen or by a C1-4 alkyl group, a heteroaryl group optionally substituted by halogen or by a C1-4 alkyl group or a cycloalkyl group; A stands for an ethylene or for a cis- or trans-vinylene or -C IDENTICAL C- group; B means a chemical bond, a -CHR -, -CHR -CH2- or a -CH2-O- group: and R means hydrogen or a C1-4 alkyl group. The compounds of the formula (I) can be used therapeutically as platelet aggregation inhibiting, anti-thrombotic, hypotensive and anti-antherosclerotic agents; they are much more stable than the natural prostacyclin derivatives.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU5251486A
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title INTERFURANYLENE-PROSTACYCLIN DERIVATIVES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A32%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAL%20HADHAZY&rft.date=1986-07-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU5251486A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true